LEETINA-A

This brand name is authorized in Nigeria.

Active ingredients

The drug LEETINA-A contains one active pharmaceutical ingredient (API):

1	Tretinoin UNII 5688UTC01R - TRETINOIN
	Tretinoin decreases cohesiveness of follicular epithelial cells resulting in decreased microcomedone formation. Additionally, tretinoin stimulates mitotic activity and increased turnover of follicular epithelial cells, causing extrusion of the comedones.
	Read more about Tretinoin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100710	Cream	LEETINA - A CREAM 30G ( 0.05%W/W) CREAM 0.05% 30G	7 NF-PP-333119 LEETINA - A CREAM 30G ( 0.05%W/W) ) TRETINOIN BP 30G TRETIONOIN BP 3OG ( EXCIPIENTS : BUTYLATED HYDROXYTOLUENE , CITRIC ACID MONOHYDRATE , EDETATE DISODIUM , LIGHT MINERAL OIL , DIMETHICONE , METHYLPARABEN ,PROPYLPARABEN , WATER ) A4-100710 Drugs Imported Products 30G Prescription Only Medicine (POM) 7/15/2023 EXCEL CHARIS PHARMACEUTICAL CHEMICAL LIMITED, 128, IKORODU ROAD 80385597 excelcharisltd@yahoo.com MERIT ORGANICS LIMITED , PLOT N0. 2104/2/1, G.I.D.C, SARIGAM, DIST. - VALSAD, GUJARAT, INDIA. , India	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D10AD01	Tretinoin	D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AD Retinoids for topical use in acne
Discover more medicines within D10AD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100710